The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic

• Auteurs principaux: Viktor Mravčík (Auteur), Barbara Janíková (Auteur), Barbora Drbohlavová (Auteur), Petr Popov (Auteur), Alessandro Pirona (Auteur)
• Format: Livre
• Publié: BMC, 2018-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Opioid agonist therapy (OAT) has been available in a standard regime in the Czech Republic since 2000. Buprenorphine is the leading medication, while methadone is available only in a few specialised centres. There is an important leakage of buprenorphine onto the illicit market, and the maj...